Stamford, CT -- (SBWIRE) -- 12/09/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Generex Biotechnology Corporation (OTCMKTS:GNBT), MannKind Corporation (NASDAQ:MNKD), Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV), Sprint Corporation (NYSE:S).
Generex Biotechnology Corporation (OTCMKTS:GNBT) ended its recent business day with the loss of -2.30% and closed at the price of $0.0297 after opening at $0.03. The stock traded during its last trading session with the total volume of 1.88 million shares, as compared to its average volume of 1.86 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Has GNBT Found The Bottom and Ready To Move Up? Find Out Here
MannKind Corporation (NASDAQ:MNKD) remained among the day advancers and traded with volume of 4.92 million shares in the last session, as compared to average volume of 4.21 million shares. In comparison with 52 week range of $2.04 - $8.70, it faced lowest price of $4.95 during the last trading session whereas its day highest price was $5.18. The company’s total market capitalization is $1.83 billion, along with 357.31 million shares outstanding. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
For How Long MNKD’s Gloss will Attract Investors? Find out via this report
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) showed 417,005.00 shares in volume during the last trading session, while the average trading volume remained 349,760.00 shares. The stock kicked off its trading session at $1.56 and closed at $1.54 after declining -1.28%. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After the Recent Fall? Just Go Here and Find Out
Sprint Corporation (NYSE:S) stock traded during its last trading session with the total traded volume of 18.08 million shares versus its average volume of 20.64 million shares. The company opened its trade at the price of $8.02 and its closing price was $7.89 after losing -1.38% for the day. Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline.
Will S Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)